WOAG
WITHDRAWAL OF ATTORNEY GRANTED
07/03/2024
Voltar para busca
Dado oficial do USPTO
THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
ST13
US500000088165746Classe
5
Pedido
88165746
Registro
7080874
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
71
Atualização mais recente
07/03/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
23/10/2018
Data de registro
13/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/06/2023
Última transação
07/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/10/2018
Primeiro uso no comércio
04/12/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
Newport Beach, CA
Examinador
LOOK, JEFFREY
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Vivera Pharmaceuticals, Inc.
Representantes
Vivera Pharmaceuticals, Inc.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular systemthe circulatory systemthe digestive systemthe excretory systemthe endocrine systemthe integumentary systemthe exocrine systemthe lymphatic systemthe immune systemthe muscular systemthe nervous systemthe renal systemthe urinary systemthe reproductive systemand/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsan analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposesfor non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD)
Publicações
Histórico de despachos e eventos da marca no USPTO.
71 publicações encontradas
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
07/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/05/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/05/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14/03/2023
DOCK
ASSIGNED TO EXAMINER
13/03/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/03/2023
PBMR
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
13/03/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2023
ALIE
ASSIGNED TO LIE
24/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/05/2022
GNRT
NON-FINAL ACTION E-MAILED
25/05/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
25/05/2022
DOCK
ASSIGNED TO EXAMINER
05/05/2022
DOCK
ASSIGNED TO EXAMINER
29/03/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/03/2022
IUAF
USE AMENDMENT FILED
23/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
23/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/10/2021
EX5G
SOU EXTENSION 5 GRANTED
14/10/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/10/2021
EXT5
SOU EXTENSION 5 FILED
11/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
20/09/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/04/2021
EX4G
SOU EXTENSION 4 GRANTED
23/04/2021
EXT4
SOU EXTENSION 4 FILED
23/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
23/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/12/2020
EX3G
SOU EXTENSION 3 GRANTED
18/12/2020
NREV
NOTICE OF REVIVAL - E-MAILED
11/12/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
11/12/2020
PETG
PETITION TO REVIVE-GRANTED
11/12/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
11/12/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
23/11/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
23/11/2020
EXT3
SOU EXTENSION 3 FILED
23/10/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/10/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/10/2020
EX2G
SOU EXTENSION 2 GRANTED
05/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/10/2020
NREV
NOTICE OF REVIVAL - E-MAILED
11/08/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
10/08/2020
PETG
PETITION TO REVIVE-GRANTED
10/08/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
10/08/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/06/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/06/2020
EXT2
SOU EXTENSION 2 FILED
23/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/11/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/10/2019
EX1G
SOU EXTENSION 1 GRANTED
16/10/2019
EXT1
SOU EXTENSION 1 FILED
16/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
16/10/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/02/2019
PUBO
PUBLISHED FOR OPPOSITION
26/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/01/2019
DOCK
ASSIGNED TO EXAMINER
15/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2018
NWAP
NEW APPLICATION ENTERED
26/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.